Pure Global

The Role of Inflammation in Myocardial Infarction - Trial NCT06065514

Access comprehensive clinical trial information for NCT06065514 through Pure Global AI's free database. This phase not specified trial is sponsored by Nicosia General Hospital and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06065514
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06065514
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Role of Inflammation in Myocardial Infarction
The Complex Role of the Inflammation Response Following an Acute Myocardial Infarction: the INFINITY (INFlammatIoN amI sTudY)

Study Focus

Myocardial Infarction

Observational

Sponsor & Location

Nicosia General Hospital

Nicosia,Thessaloniki,Thessaloniki,Thessaloniki, Cyprus,Greece

Timeline & Enrollment

N/A

Aug 24, 2023

May 30, 2025

120 participants

Primary Outcome

Incidence of Mortality

Summary

The aim of this research is to study the prognostic role of a selected combination of
 cytokines and adipokines in patients with myocardial infarction, as well as to determine
 their role in the development of adverse cardiac remodeling.

ICD-10 Classifications

Acute myocardial infarction
Acute myocardial infarction, unspecified
Old myocardial infarction
Subsequent myocardial infarction
Observation for suspected myocardial infarction

Data Source

ClinicalTrials.gov

NCT06065514

Non-Device Trial